Mydayis 54092-0477-01
Generic: Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, And Amphetamine Sulfate
- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Dosage Form
- Capsule, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- June 20, 2017
- Listing Expires
- December 31, 2027
- Application
- NDA022063
Active Ingredients
| Ingredient | Strength |
|---|---|
| Amphetamine Aspartate Monohydrate | 12.5 mg/1 |
| Amphetamine Sulfate | 12.5 mg/1 |
| Dextroamphetamine Saccharate | 12.5 mg/1 |
| Dextroamphetamine Sulfate | 12.5 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulant [EPC]Central Nervous System Stimulant [EPC]
Selected Package
54092-0477-01Selected100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-477-01)